PERSPECTA

News from every angle

Back to headlines

AgomAb Therapeutics (AGMB) Secures U.S. Patent for AGMB-447

AgomAb Therapeutics (AGMB) has been granted a U.S. patent for its compound AGMB-447.

12 Apr, 18:46 — 12 Apr, 18:46
PostShare

Sources

Showing 1 of 1 sources